Home
Conditions
Lobular Breast Carcinoma in Situ

Clinical trial condition

Lobular Breast Carcinoma in Situ

Explore clinical trials studying Lobular Breast Carcinoma in Situ. Study availability and eligibility vary by location and protocol.

16 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Lobular Breast Carcinoma in Situ trial results

Active, not recruiting

Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer

NCT02515110

Conditions: Breast Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +13 more
Locations: Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States

VCU Community Memorial Healthcenter South Hill, Virginia, United States

View Trial Details

Active, not recruiting

Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer

NCT01905046

Conditions: Adenocarcinoma, Atypical Ductal Breast Hyperplasia, BRCA1 Mutation Carrier, +16 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

Los Angeles County-USC Medical Center Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

City of Hope South Pasadena South Pasadena, California, United States

View all 27 locations

View Trial Details

Active, not recruiting

Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE)

NCT04496739

Conditions: Atypical Hyperplasia of the Breast, Breast Carcinoma In Situ, Breast Diseases, +11 more
Locations: Kaiser Permanente-Deer Valley Medical Center Antioch, California, United States

UC Irvine Health Cancer Center-Newport Costa Mesa, California, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

Kaiser Permanente-Oakland Oakland, California, United States

View all 97 locations

View Trial Details

Completed

Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy

NCT01819233

Conditions: Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +21 more
Locations: Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer

NCT01706432

Conditions: Adenocarcinoma, Brain Diseases, Brain Neoplasms, +36 more
Locations: University of Chicago North Chicago, Illinois, United States

View Trial Details

Completed

Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer

NCT01219075

Conditions: Adenocarcinoma, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, +20 more
Locations: University of Southern California Los Angeles, California, United States

View Trial Details

Completed

Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy

NCT02314156

Conditions: Adenocarcinoma, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, +20 more
Locations: Cedars-Sinai Medical Center West Hollywood, California, United States

Northwestern University Chicago, Illinois, United States

Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors

NCT01849250

Conditions: Adenocarcinoma, Benign Breast Neoplasm, Breast Carcinoma In Situ, +24 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

Columbia University/Herbert Irving Cancer Center New York, United States

Memorial Sloan-Kettering Cancer Center New York, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Oxybutynin Chloride in Managing Hot Flashes

NCT02961790

Conditions: Adenocarcinoma, Breast Carcinoma, Breast Carcinoma In Situ, +18 more
Locations: Illinois CancerCare-Peoria Peoria, Illinois, United States

Carle Cancer Center NCI Community Oncology Research Program Urbana, Illinois, United States

Oncology Associates at Mercy Medical Center Cedar Rapids, Iowa, United States

Cancer Center of Kansas - Wichita Wichita, Kansas, United States

View all 13 locations

View Trial Details

Completed

Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer

NCT01869764

Conditions: Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +21 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Lobular Breast Carcinoma in Situ

Lobular Breast Carcinoma in Situ trial results

Related conditions